| Argen-X N.V. (Argenx). (2/4/19). "Press Release: Argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology". Breda, Ghent & San Diego, CA. |
2019-02-04 |
| Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. |
2019-02-04 |
| Curetis N.V.. (1/30/19). "Press Release: Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand". Amsterdam & Holzgerlingen. |
2019-01-30 |
| Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Successfully Raises EUR 55.50 Milion in an Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. |
2019-01-23 |
| Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Upsizes Its Equity Placement Due to Significant Demand [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. |
2019-01-23 |
| Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Launches Equity Placement [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen. |
2019-01-23 |
| Uniqure N.V.. (1/22/19). "Press Release: Uniqure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease". Lexington, MA & Amsterdam. |
2019-01-22 |
| Minoryx Therapeutics S.L.. (1/15/19). "Press Release: Minoryx Therapeutics Extends Its Activities in Belgium". Mataró, Barcelona & Charleroi. |
2019-01-15 |
| Bioké (Cell Signaling Technology Europe B.V.). (1/14/19). "Press Release: Bioké and OLS Omni Life Science Announce a Distribution Agreement for the BeNeLux Countries". Leiden. |
2019-01-14 |
| Qiagen N.V.. (1/14/19). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Gains Approval in Canada". Germantown, MD & Hilden. |
2019-01-14 |
| Formulatrix, Inc.. (1/10/19). "Press Release: Formulatrix Digital PCR Technology to Be Acquired by Qiagen". Bedford, MA. |
2019-01-10 |
| Galapagos N.V.. (1/8/19). "Press Release: Sands Capital Reports 5.7% Holding in Galapagos". Mechelen. |
2019-01-08 |
| Qiagen N.V.. (1/7/19). "Press Release: Qiagen Unveils Plans for Next-generation Digital PCR Systems". Hilden & Germantown, MD. |
2019-01-07 |
| Galapagos N.V.. (1/7/19). "Press Release: Galapagos Starts First Phase 1 Trial with Toledo Compound". Mechelen. |
2019-01-07 |
| Galapagos N.V.. (1/6/19). "Press Release: Galapagos Initiates NOVESA Phase 2a Trial in Patients with Systemic Sclerosis". Mechelen. |
2019-01-06 |
| Galapagos N.V.. (1/4/19). "Press Release: Fibrocor and Galapagos Sign Partnership in Fibrosis". Mechelen. |
2019-01-04 |
| Kiadis Pharma N.V.. (1/4/19). "Press Release: Kiadis Pharma Expands Presence in the United States". Amsterdam & Boston, MA. |
2019-01-04 |
| Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent. |
2019-01-03 |
| Promethera Biosciences S.A.. (1/2/19). "Press Release: Promethera Biosciences Announces Investment by Itochu Corporation and a Broad Strategic Collaboration to Access the Asian Markets". Mont-Saint-Guibert & Tokyo. |
2019-01-02 |
| Galapagos N.V.. (12/17/18). "Press Release: Galapagos Reports Initiation of ISABELA Phase 3 Program with GLPG1690 in Patients with Idiopathic Pulmonary Fibrosis (IPF)". Mechelen. |
2018-12-17 |
| Noxxon Pharma N.V.. (12/14/18). "Press Release: Noxxon Announces Key Findings that NOX-A12 plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients". Berlin. |
2018-12-14 |
| Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-12-13 |
| Qiagen N.V.. (12/6/18). "Press Release: Qiagen Announces New Collaboration to Develop Companion Diagnostic to Guide Treatment for Patients with PIK3CA-mutated Advanced Breast Cancer". Germantown, MD & Hilden. |
2018-12-06 |
| Confo Therapeutics N.V.. (12/6/18). "Press Release: Confo Therapeutics Appoints Frank Landolt as Its Chief Counsel Legal & Intellectual Property". Ghent. |
2018-12-06 |
| Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia". Breda & Ghent. |
2018-12-03 |
| Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. |
2018-12-03 |
| Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen. |
2018-12-03 |
| MaSTherCell S.A.. (11/30/18). "Press Release: MaSTherCell Expands Production by Doubling Its Capacity". Gosselies. |
2018-11-30 |
| Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL. |
2018-11-30 |
| Forbion Capital Partners. (11/29/18). "Press Release: Forbion Appoints Dr. Carlo Incerti as Operating Partner". Naarden & Munich. |
2018-11-29 |
| Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen. |
2018-11-29 |
| Qiagen N.V.. (11/28/18). "Press Release: Qiagen Extends Comprehensive Offering for Cervical Cancer Screening with European Launch of QIAscreen HPV PCR Test". Hilden. |
2018-11-28 |
| Galapagos N.V.. (11/27/18). "Press Release: Galapagos Receives Fast Track Designation from FDA for GLPG1972/S201086 in Osteoarthritis". Mechelen. |
2018-11-27 |
| Inkef Capital B.V.. (11/27/18). "Press Release: Inkef Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund". Amsterdam. |
2018-11-27 |
| Eurofins Scientific. (11/26/18). "Press Release: Eurofins Further Reduces Its Financing Costs after Redeeming Its EUR 300m November 2018 Eurobond and Extends Its Organic Growth Objectives beyond 2020". |
2018-11-26 |
| Merck KGaA. (11/23/18). "Press Release: Merck Appoints Jasper Bos as Managing Director of M Ventures". Darmstadt. |
2018-11-23 |
| Curetis N.V.. (11/23/18). "Press Release: Curetis Announces Financial Results for the First Nine Months of 2018". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-11-23 |
| Celyad S.A.. (11/21/18). "Press Release: Celyad Announces Third Quarter 2018 Business Update". Mont-Saint-Guibert. |
2018-11-21 |
| InflaRx N.V.. (11/21/18). "Press Release: InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results". Jena. |
2018-11-21 |
| Noxxon Pharma N.V.. (11/16/18). "Press Release: Noxxon Announces € 6.2 Million Equity Capital Raise including US$ 5 Million from US Family Office – Acuitas Capital, LLC. Noxxon Ends the Use of Variable Rate Equity Financing with Yorkville". Berlin. |
2018-11-16 |
| Life Sciences Partners (LSP). (11/12/18). "Press Release: LSP Raises Record €750 Million in 10 Months for Life Sciences Innovations [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE U |
2018-11-12 |
| Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. |
2018-11-08 |
| InflaRx N.V.. (11/8/18). "Press Release: InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. |
2018-11-08 |
| Kiadis Pharma N.V.. (11/8/18). "Press Release: Kiadis Pharma Strengthens Core Team with Three Senior Appointments". Amsterdam. |
2018-11-08 |
| Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies. |
2018-11-07 |
| Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-11-07 |
| Bone Therapeutics S.A.. (11/6/18). "Press Release: Bone Therapeutics Announces Conclusions from Interim Analysis of Phase III PREOB Study in Hip Osteonecrosis". Gosselies. |
2018-11-06 |
| Imcyse S.A.. (11/5/18). "Press Release: Imcyse Successfully Completes Patient Enrollment in First-in-human Phase 1B Study in Type 1 Diabetes". Liège. |
2018-11-05 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. |
2018-11-02 |
| Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol |
2018-11-02 |
| Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. |
2018-11-01 |
| ProQR Therapeutics N.V.. (10/29/18). "Press Release: ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals". Leiden. |
2018-10-29 |
| Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. |
2018-10-29 |
| Bone Therapeutics S.A.. (10/29/18). "Press Release: Bone Therapeutics Announces Appointment of Linda Lebon as Chief Regulatory Officer". Gosselies. |
2018-10-29 |
| Apitope International N.V.. (10/24/18). "Press Release: Apitope Announces Management Changes. Keith Martin to Retire as CEO, Continue as Non-Executive Director – Hayley French Appointed COO and Interim CEO". Hasselt & Chepstow. |
2018-10-24 |
| Kiadis Pharma N.V.. (10/19/18). "Press Release: Kiadis Pharma Raises €31.2 Million in a Private Placement of 3.9 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam. |
2018-10-19 |
| MaSTherCell S.A.. (10/18/18). "Press Release: Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe". San Carlos, CA & Gosselies. |
2018-10-18 |
| Kiadis Pharma N.V.. (10/18/18). "Press Release: Kiadis Pharma Launches a Private placement of approximately 3.7 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam. |
2018-10-18 |
| Breath Therapeutics B.V.. (10/17/18). "Press Release: Breath Therapeutics Appoints Peter Shadday as Chief Commercial Officer". Munich. |
2018-10-17 |
| Kiadis Pharma N.V.. (10/12/18). "Press Release: Kiadis Pharma Provides Regulatory and Clinical Update on ATIR101". Amsterdam. |
2018-10-12 |
| Curetis N.V.. (10/11/18). "Press Release: Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-10-11 |
| European Commission. (10/11/18). "Press Release: A New Bioeconomy Strategy for a Sustainable Europe. Commission Puts Forward an Action Plan to Develop a Sustainable and Circular Bioeconomy that Serves Europe's Society, Environment and Economy". Brussels. |
2018-10-11 |
| Forbion Capital Partners. (10/10/18). "Press Release: Forbion Co-leads $54m Series A Financing in Newly Formed Gotham Therapeutics". Naarden & Munich. |
2018-10-10 |
| Argen-X N.V. (Argenx). (10/9/18). "Press Release: Argenx Awarded €2.6 Million VLAIO Grant to Explore New Applications of ABDEG Technology". Breda & Ghent. |
2018-10-09 |
| Nouryon (Starfruit Holdco B.V.). (10/9/18). "Press Release: AkzoNobel Specialty Chemicals is Now Nouryon". |
2018-10-09 |
| Promethera Biosciences S.A.. (10/5/18). "Press Release: Promethera Biosciences Appoints Mutsuki Takano to Group Chief Financial Officer". Mont-Saint-Guibert. |
2018-10-05 |
| Celyad S.A.. (10/4/18). "Press Release: Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop NextGeneration Allogeneic CAR-T Therapies". Mont-Saint-Guibert. |
2018-10-04 |
| Novasep S.A.. (10/2/18). "Press Release: Novasep Opens €27m New Viral Vector Commercial Production Facility". Lyon. |
2018-10-02 |
| Curetis N.V.. (10/2/18). "Press Release: Curetis Secures Financing Facility of up to EUR 20 Million through the Issuance of Convertible Notes". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-10-02 |
| Forbion Capital Partners. (10/1/18). "Press Release: Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 Million". Naarden & Munich. |
2018-10-01 |
| MaSTherCell S.A.. (10/1/18). "Press Release: KangStem Biotech Selects MaSTherCell for GMP Manufacturing of Furestem-AD in Europe". Seoul & Gosselies. |
2018-10-01 |
| Eurofins Scientific. (10/1/18). "Press Release: Eurofins to Expand Its US Environment Testing Offering with the Acquisition of TestAmerica". |
2018-10-01 |
| Celyad S.A.. (9/26/18). "Press Release: Celyad Appoints Carri Duncan as Vice-President Corporate Development and Communications". Mont-Saint-Guibert. |
2018-09-26 |
| InflaRx N.V.. (9/21/18). "Press Release: InflaRx N.V. Announces Appointment of Jens Holstein to Board of Directors". Jena. |
2018-09-21 |
| Argen-X N.V. (Argenx). (9/21/18). "Press Release: Argenx Announces Closing of U.S. Public Offering". Breda & Ghent. |
2018-09-21 |
| Argen-X N.V. (Argenx). (9/19/18). "Press Release: Argenx Raises approximately $300.6 Million in Gross Proceeds in a U.S. Public Offering". Breda & Ghent. |
2018-09-19 |
| Argen-X N.V. (Argenx). (9/17/18). "Press Release: Argenx Reports Positive Topline Results from Phase 2 Proof-of-Concept Trial of Efgartigimod in Primary Immune Thrombocytopenia". Breda & Ghent. |
2018-09-17 |
| Argen-X N.V. (Argenx). (9/17/18). "Press Release: Argenx Announces Launch of Proposed Public Offering in the United States". Breda & Ghent. |
2018-09-17 |
| Qiagen N.V.. (9/17/18). "Press Release: Qiagen and NeuMoDx Announce Strategic Partnership to Offer Next-generation Systems for Fully Integrated Molecular Diagnostic Testing". Hilden & Ann Arbor, MI. |
2018-09-17 |
| Qiagen N.V.. (9/17/18). "Press Release: Qiagen and DiaSorin Launch Automated Testing for Latent TB Infection with QuantiFERON-TB Gold Plus Technology on Widely Used Liaison Platforms". Hilden & Saluggia. |
2018-09-17 |
| Bone Therapeutics S.A.. (9/14/18). "Press Release: Bone Therapeutics Announces Final Results from Phase I/IIA ALLOB Delayed-union Fracture Study". Gosselies. |
2018-09-14 |
| Galapagos N.V.. (9/13/18). "Press Release: Galapagos Raises $300 Million Gross Proceeds in a U.S. Public Offering". Mechelen. |
2018-09-13 |
| Galapagos N.V.. (9/12/18). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen. |
2018-09-12 |
| Qiagen N.V.. (9/12/18). "Press Release: Qiagen to Join Germany’s MDAX Index in Addition to TecDAX". Hilden & Germantown, MD. |
2018-09-12 |
| Galapagos N.V.. (9/11/18). "Press Release: Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis". Foster City, CA & Mechelen. |
2018-09-11 |
| Oxurion N.V.. (9/10/18). "Press Release: Oxurion NV Announces New Euronext Brussels Stock Ticker “OXUR” and Launch of New Website". Leuven. |
2018-09-10 |
| European Invesmtent Bank (EIB). (9/7/18). "Press Release: Investment Plan for Europe – the EIB and Grifols Sign a New Loan Agreement to Advance Research on Rare and Chronic Diseases". |
2018-09-07 |
| Argen-X N.V. (Argenx). (9/6/18). "Press Release: Argenx Doses First Patient in Global Phase 3 Registration Trial of Efgartigimod". Breda & Ghent. |
2018-09-06 |
| Eurofins. (9/4/18). "Press Release: Eurofins Expands Its Leading Global Cosmetic Testing Footprint with the Acquisition of Clinical Research Laboratories in North America". |
2018-09-04 |
| Miracor Medical S.A.. (9/4/18). "Press Release: Miracor Medical Closes Final Tranche of Series D, Bringing the Round to €30M". Awans. |
2018-09-04 |
| NTrans Technologies B.V.. (9/4/18). "Press Release: NTrans Technologies Receives Horizon 2020 SME Grant". |
2018-09-04 |
| EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels. |
2018-09-03 |
| Biocartis Group N.V.. (9/3/18). "Press Release: Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla Platform in China". Mechelen & Guangzhou. |
2018-09-03 |
| Kiadis Pharma N.V.. (8/30/18). "Press Release: Kiadis Pharma Announces Resignation of Robbert van Heekeren and Appoints Scott A. Holmes as New Chief Financial Officer". Amsterdam. |
2018-08-30 |
| Biocartis Group N.V.. (8/28/18). "Press Release: Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy". Mechelen. |
2018-08-28 |
| Uniqure N.V.. (8/23/18). "Press Release: Uniqure Announces First Patient Treated in Dose-confirmation Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. |
2018-08-23 |
| Argen-X N.V. (Argenx). (8/22/18). "Press Release: Argenx Announces that AbbVie Has Exercised Its Exclusive Option to License ARGX-115, a Novel Immuno-oncology Antibody". Breda & Ghent. |
2018-08-22 |
| Uniqure N.V.. (8/8/18). "Press Release: Uniqure Announces Second Quarter 2018 Financial Results and Highlights Company Progress". Lexington, MA & Amsterdam. |
2018-08-08 |
| Celyad S.A.. (8/7/18). "Press Release: Celyad Appoints Filippo Petti as Chief Financial Officer". Mont-Saint-Guibert. |
2018-08-07 |
| Argen-X N.V. (Argenx). (8/2/18). "Press Release: Argenx Reports Second Quarter Business Update and Half-year 2018 Financial Results". Breda & Ghent. |
2018-08-02 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
